Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New PDE4 inhibitor CI-1044 may be useful in COPD, according to ERS presentation

Sep. 28, 2001

ERS highlights: NIK-616 may have advantages for Rx of asthma and COPD

Sep. 28, 2001

Intratracheal AWD-12-281 significantly reduces LPS-induced BALF neutrophilia in pigs

Sep. 28, 2001

Genaera receives Cystic Fibrosis Foundation grant to develop Lomucin

Sep. 27, 2001

Inflazyme initiates two trials to study novel antiinflammatory compounds

Sep. 27, 2001

Surfaxin not associated with changes in fetal human pulmonary cell physiology

Sep. 27, 2001

COPD the third indication to be explored for ABX-IL-8

Sep. 26, 2001

Phase III multinational clinical trial of Surfaxin launched in IRDS

Sep. 26, 2001

CAT antibody displays human eotaxin-neutralizing activity in vitro and in vivo

Sep. 26, 2001

CDP-840 attenuates increased TNF-alpha synthesis in healthy subjects

Sep. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...